コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 25 million MSCs was found to achieve optimal cartilage repair.
2 nhanced differentiation capacity for bone or cartilage repair.
3 critical properties that significant impact cartilage repair.
4 d more effective delivery systems to promote cartilage repair.
5 ) perivascular population, and contribute to cartilage repair.
6 reases contribution of Gdf5-lineage cells to cartilage repair.
7 rphologic assessment of the knee joint after cartilage repair.
8 se PHD-2 may represent a relevant target for cartilage repair.
9 esting their potential utility for articular cartilage repair.
10 an chondrocyte function and a new target for cartilage repair.
11 ential in engineered cartilage formation and cartilage repair.
12 n the nanoscale for application to articular cartilage repair.
13 nce in formulating effective stem cell-based cartilage repair.
14 iation and of cell replacement therapies for cartilage repair.
15 e application of growth factors to articular cartilage repair.
16 tor involved in chondrogenesis and articular cartilage repair.
17 s in vitro and in vivo and enhance articular cartilage repair.
18 practical utility for tissue engineering and cartilage repair.
19 rtilage lubrication, can inhibit integrative cartilage repair.
20 CPII, both of which are putative markers of cartilage repair.
21 ns reduced inflammation and greatly improved cartilage repair.
22 itate finding an alternative cell source for cartilage repair.
23 io), thus showing superior potential towards cartilage repair.
24 fibrosis, inflammation, chondrogenesis, and cartilage repair.
26 therapeutic solution for targeted articular cartilage repair, allowing for a controlled and minimall
27 (MSCs) provide an attractive cell source for cartilage repair and cell therapy; however, the underlyi
29 elf-assembling peptide hydrogel scaffold for cartilage repair and developed a method to encapsulate c
30 cost-effective GAG manipulation approach to cartilage repair and joint preservation, offering insigh
31 a unique model for adult chondrogenesis and cartilage repair and may serve as inspiration for novel
35 of tissue-engineered products for articular cartilage repair and particularly cell-based therapies.
37 itional MR imaging techniques for imaging of cartilage repair and their application to longitudinal s
38 critical properties involved in MSC-induced cartilage repair, and adapted for other clinical indicat
40 ulin-like growth factor 1 (IGF-1) stimulates cartilage repair but is not a practical therapy due to i
42 are an attractive allogeneic cell source for cartilage repair, but their clinical translation has bee
43 ro and improved the persistence of articular cartilage repair by preventing vascularization and bone
44 se effects of NO may result in impairment of cartilage repair, by interfering with the extracellular
45 l loss at 2 weeks correlated with incomplete cartilage repair, diagnosed at histopathologic examinati
46 ant issue affecting the use of stem cells in cartilage repair, especially with regard to the persiste
47 e entire limbs, digit tip regrowth and joint cartilage repair following joint distraction suggest lat
50 ng-based treatment of osteoarthritis and for cartilage repair in animal models and clinical trials ar
51 ransplantation revealed significantly better cartilage repair in animals that received BMP-4-transduc
52 -invasive therapeutic modality for articular cartilage repair in future preclinical and clinical rese
53 have previously found that the capacity for cartilage repair in human adult articular chondrocytes i
54 brid biomimetic scaffold as a niche to favor cartilage repair in mechanically active joints using a c
55 Gdf5 expression was also upregulated during cartilage repair in mice and was switched on in injured
56 d mesenchymal stem cells (MSCs) and enhances cartilage repair in mouse osteoarthritis (OA) models.
63 enge in choosing an appropriate scaffold for cartilage repair is the identification of a material tha
65 were correlated with quantitative scores for cartilage repair (MOCART score and ICRS score) at 12 wee
67 lopment of tissue engineering approaches for cartilage repair or regeneration for the treatment of jo
69 msec +/- 1.8; P < .001) and no difference in cartilage repair outcomes compared with unlabeled contro
71 ascular injury in immature epiphyses affects cartilage repair outcomes of matrix-associated stem cell
74 successfully engineered tissues, but today, cartilage repair products are few and they exhibit consi
77 hat HA/RHAMM interactions play a key role in cartilage repair/regeneration via stimulating inflammato
79 enabled precise prediction of post-treatment cartilage repair scores with coefficient of determinatio
82 the efficacy of pharmacologic treatments and cartilage repair strategies, but noninvasive techniques
84 f strategies and technologies for cell-based cartilage repair, such as the disconnect between univers
85 drocytes group achieved substantially better cartilage repair than the chondrocytes-alone group that
87 potential clinical applications; cell-based cartilage repair therapies require significant in vitro
90 were assessed by using the MR observation of cartilage repair tissue (MOCART) score (scale, 0-100), t
95 gmented microfracture significantly improves cartilage repair with a collagen fiber orientation more